Abstract
Background
Limited data are available in relation to the clinical features of PIBO undergoing prolonged nebulization treatment with budesonide, terbutaline and ipratropium bromide. This retrospective study aimed to outline the features of clinical, high-resolution computed tomography (HRCT) and pulmonary function test (PFT) of PIBO, undergoing maintenance therapy utilizing a triple nebulization treatment and to determine the factors associated with prognosis.
Methods
Children diagnosed with PIBO were followed up between April 2014 and March 2017. The clinical features after maintenance nebulization treatment for 12 months were thereafter summarized.
Results
Thirty patients, 21 boys and 9 girls, were enrolled in the study. The median age of patients was 17.4 months, with a range between 3.0 and 33 months. Persistent coughing and wheezing were detected whilst wheezing and crackles were the common manifestations presented. HRCT scans revealed patchy ground and glass opacity, while PFT showed fixed airway obstruction in all patients. Four patients were lost during follow-up. After treatment, the clinical symptoms were improved greatly in all patients (P < 0.01). The mean increase in the percentage of TPEF%TE and VPEF%VE were improved greatly (P < 0.01). Images of the HRCT scan indicated marked improvements in 18 patients (81.8%) in comparison with scans obtained pre-treatment.
Conclusions
Our data suggest a potential role of long-term nebulization treatment of budesonide, terbutaline, ipratropium bromide on PIBO, due to its efficacy as indicated in the improved clinical symptoms, pulmonary functions and CT manifestations identified in the children. New prospective and controlled studies are required to confirm this proposition.
Similar content being viewed by others
References
Smith KJ, Fan LL. Insights into post-infectious bronchiolitis obliterans in children. Thorax. 2006;61:462–3.
Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr. 2014;14:238.
Kim JS, Kim CK, Kim SW, Koh YY, Cohen AH, Deterding RR, White CW. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest. 2001;120:1101–6.
Aleman C, Alegre J, Recio J, Fernandez DST. Bronchiolitis obliterans organizing pneumonia associated with Legionella pneumophila. An Med Interna. 2002;19:133–5.
Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol. 2006;41:947–53.
Koh YY, Jung DE, Koh JY, Kim JY, Yoo Y, Kim CK. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest. 2007;131:1454–60.
Chiu C, Wong K, Huang Y, Lin T. Bronchiolitis obliterans in children: clinical presentation, therapy and long-term follow-up. J Paediatr Child Health. 2008;44:129–33.
Murtagh P, Giubergia V, Viale D, Bauer G, Pena HG. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol. 2009;44:450–6.
Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol. 2002;33:466–74.
Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010;11:233–9.
Mattiello R, Sarria EE, Mallol J, Fischer GB, Mocelin H, Bello R, et al. Post-infectious bronchiolitis obliterans: can CT scan findings at early age anticipate lung function? Pediatr Pulmonol. 2010;45:315–9.
Colom AJ, Maffey A, Garcia Bournissen F, Teper A. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up. Thorax. 2015;70:169–74.
Bosa VL, Mello ED, Mocelin HT, Benedetti FJ, Fischer GB. Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr. 2008;84:323–30.
Uyan ZS, Turan I, Ay P, Cakir E, Ozturk E, Gedik AH, et al. Sleep disordered breathing and sleep quality in children with bronchiolitis obliterans. Pediatr Pulmonol. 2016;51:308–15.
Cullinan P, Bush A. Growing old(er) with postinfectious bronchiolitis obliterans. Thorax. 2015;70:103–4.
Bashoura L, Gupta S, Jain A, Couriel DR, Komanduri KV, Eapen GA, et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transpl. 2008;41:63–7.
Kim SW, Rhee CK, Kim YJ, Lee S, Kim HJ, Lee JW. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Respir Res. 2016;17:63.
Tomikawa SO, Adde FV, da Silva Filho LV, Leone C, Rodrigues JC. Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy. Orphanet J Rare Dis. 2014;9:128.
Lobo AL, Guardiano M, Nunes T, Azevedo I, Vaz LG. Post-infectious bronchiolitis obliterans in children. Rev Port Pneumol. 2007;13:495–509.
Calabrese C, Corcione N, Rea G, Stefanelli F, Meoli I, Vatrella A. Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans. J Bras Pneumol. 2016;42:228–31.
Xie BQ, Wang W, Zhang WQ, Guo XH, Yang MF, Wang L, et al. Ventilation/perfusion scintigraphy in children with post-infectious bronchiolitis obliterans: a pilot study. PLoS One. 2014;9:e98381.
Zhang L, Irion K, Kozakewich H, Reid L, Camargo JJ, da Silva Porto N, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2000;29:341–50.
Colom AJ, Teper AM, Vollmer WM, Diette GB. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax. 2006;61:503–6.
Chan PW, Muridan R, Debruyne JA. Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology. 2000;5:369–75.
Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol. 2009;44:1065–9.
Wang X, Liu C, Wang M, Zhang YI, Li H, Liu G. Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment. Exp Ther Med. 2015;9:2379–83.
Rosewich M, Eckrich J, Zielen S. Long-term lung function in postinfectious bronchiolitis obliterans. Thorax. 2015;70:792.
Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2008;43:381–390.
Rosewich M, Zissler UM, Kheiri T, Voss S, Eickmeier O, Schulze J, et al. Airway inflammation in children and adolescents with bronchiolitis obliterans. Cytokine. 2015;73:156–62.
Eckrich J, Herrmann E, Voss S, Schubert R, Zielen S, Rosewich M. Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans. Lung. 2016;194:571–9.
Castro-Rodriguez JA, Giubergia V, Fischer GB, Castanos C, Sarria EE, Gonzalez R, et al. Postinfectious bronchiolitis obliterans in children: the South American contribution. Acta Paediatr. 2014;103:913–21.
Yu J. Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation. Korean J Pediatr. 2015;58:459.
Aguerre V, Castanos C, Pena HG, Grenoville M, Murtagh P. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol. 2010;45:1180–5.
Mosquera RA, Hashmi SS, Pacheco SE, Reverdin A, Chevallier J, Colasurdo GN. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans. Clin Respir J. 2014;8:63–71.
Funding
No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.
Author information
Authors and Affiliations
Contributions
XMZ, AZL and HWY had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. XMZ, AZL, and XBZ. conceived and designed the study. XMZ and AZL reviewed the scientific literature, did the statistical analysis, prepared all tables and figures, and wrote the first draft of the report. LLQ, LBW and XBZ reviewed and revised the article. All authors made a critical revision of the manuscript for key intellectual content.
Corresponding author
Ethics declarations
Ethical approval
This study was approved by the Hospital’s Ethics Committee, and all participants provided written consents.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhang, XM., Lu, AZ., Yang, HW. et al. Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment. World J Pediatr 14, 498–503 (2018). https://doi.org/10.1007/s12519-018-0193-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-018-0193-z